Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects

BACKGROUND: A once-daily (o.d.) fixed-dose combination of indacaterol acetate (IND), glycopyrronium bromide (GLY), and mometasone furoate (MF) delivered via the Breezhaler(®) device (IND/GLY/MF) is being developed for treatment of asthma. This study compared steady-state pharmacokinetics of IND, GLY...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Satoru, Vaidya, Soniya, Tillmann, Hanns-Christian, Sakita, Yohei, Machineni, Surendra, Heudi, Olivier, Furihata, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791651/
https://www.ncbi.nlm.nih.gov/pubmed/33413291
http://dx.doi.org/10.1186/s12890-020-01382-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791651/
https://www.ncbi.nlm.nih.gov/pubmed/33413291
http://dx.doi.org/10.1186/s12890-020-01382-6

Ejemplares similares